Cargando…
The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
OBJECTIVES: MRI is an integral part of breast cancer screening in high-risk patients. We investigated whether the application of the Kaiser score, a clinical decision-support tool, may be used to exclude malignancy in contrast-enhancing lesions classified as BI-RADS 4 on breast MRI screening exams....
Autores principales: | Milos, Ruxandra Iulia, Pipan, Francesca, Kalovidouri, Anastasia, Clauser, Paola, Kapetas, Panagiotis, Bernathova, Maria, Helbich, Thomas H., Baltzer, Pascal A. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553895/ https://www.ncbi.nlm.nih.gov/pubmed/32504098 http://dx.doi.org/10.1007/s00330-020-06945-z |
Ejemplares similares
-
Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI
por: Wengert, G. J., et al.
Publicado: (2019) -
Breast MRI: does a clinical decision algorithm outweigh reader experience?
por: Pötsch, Nina, et al.
Publicado: (2022) -
One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
por: Clauser, Paola, et al.
Publicado: (2021) -
Inter- and intra-observer agreement of BI-RADS-based subjective visual estimation of amount of fibroglandular breast tissue with magnetic resonance imaging: comparison to automated quantitative assessment
por: Wengert, G. J., et al.
Publicado: (2016) -
Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis
por: Spick, Claudio, et al.
Publicado: (2017)